Selected research
Industry Research
Ophthalmic Steroids Drug Industry Research Report 2026
Market perspective
The global Ophthalmic Steroids Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ophthalmic Steroids Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ophthalmic Steroids Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ophthalmic Steroids Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ophthalmic Steroids Drug include Alimera Sciences, Allergan, Bausch and Lomb, Genentech, Novartis AG, Regeneron Pharmaceuticals, Valeant Pharmaceuticals International, Bayer AG and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ophthalmic Steroids Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ophthalmic Steroids Drug Market by Company
Alimera Sciences
Allergan
Bausch and Lomb
Genentech
Novartis AG
Regeneron Pharmaceuticals
Valeant Pharmaceuticals International
Bayer AG
GlaxoSmithKline
Pfizer
Ophthalmic Steroids Drug Segment by Type
Allergic Conjunctivitis
Keratitis
Uveitis
Diabetic Macular Edema
Others
Ophthalmic Steroids Drug Segment by Application
Retail Pharmacies
Online Pharmacies
Research Institute
Hospital Pharmacies
Others
Ophthalmic Steroids Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Steroids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Steroids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Steroids Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ophthalmic Steroids Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ophthalmic Steroids Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ophthalmic Steroids Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Allergic Conjunctivitis
- Keratitis
- Uveitis
- Diabetic Macular Edema
- Others
Applications
- Retail Pharmacies
- Online Pharmacies
- Research Institute
- Hospital Pharmacies
- Others
Companies covered
- Alimera Sciences
- Allergan
- Bausch and Lomb
- Genentech
- Novartis AG
- Regeneron Pharmaceuticals
- Valeant Pharmaceuticals International
- Bayer AG
- GlaxoSmithKline
- Pfizer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ophthalmic Steroids Drug Market Size (2021-2032)
- 2.2.2 Global Ophthalmic Steroids Drug Sales (2021-2032)
- 2.2.3 Global Ophthalmic Steroids Drug Market Average Price (2021-2032)
- 2.3 Ophthalmic Steroids Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Allergic Conjunctivitis
- 2.3.3 Keratitis
- 2.3.4 Uveitis
- 2.3.5 Diabetic Macular Edema
- 2.3.6 Others
- 2.4 Ophthalmic Steroids Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Research Institute
- 2.4.5 Hospital Pharmacies
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ophthalmic Steroids Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ophthalmic Steroids Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Ophthalmic Steroids Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Ophthalmic Steroids Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Ophthalmic Steroids Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ophthalmic Steroids Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ophthalmic Steroids Drug, Product Type & Application
- 3.8 Global Manufacturers of Ophthalmic Steroids Drug, Established Date
- 3.9 Global Ophthalmic Steroids Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alimera Sciences
- 4.1.1 Alimera Sciences Company Information
- 4.1.2 Alimera Sciences Business Overview
- 4.1.3 Alimera Sciences Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alimera Sciences Ophthalmic Steroids Drug Product Portfolio
- 4.1.5 Alimera Sciences Recent Developments
- 4.2 Allergan
- 4.2.1 Allergan Company Information
- 4.2.2 Allergan Business Overview
- 4.2.3 Allergan Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Allergan Ophthalmic Steroids Drug Product Portfolio
- 4.2.5 Allergan Recent Developments
- 4.3 Bausch and Lomb
- 4.3.1 Bausch and Lomb Company Information
- 4.3.2 Bausch and Lomb Business Overview
- 4.3.3 Bausch and Lomb Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bausch and Lomb Ophthalmic Steroids Drug Product Portfolio
- 4.3.5 Bausch and Lomb Recent Developments
- 4.4 Genentech
- 4.4.1 Genentech Company Information
- 4.4.2 Genentech Business Overview
- 4.4.3 Genentech Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Genentech Ophthalmic Steroids Drug Product Portfolio
- 4.4.5 Genentech Recent Developments
- 4.5 Novartis AG
- 4.5.1 Novartis AG Company Information
- 4.5.2 Novartis AG Business Overview
- 4.5.3 Novartis AG Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis AG Ophthalmic Steroids Drug Product Portfolio
- 4.5.5 Novartis AG Recent Developments
- 4.6 Regeneron Pharmaceuticals
- 4.6.1 Regeneron Pharmaceuticals Company Information
- 4.6.2 Regeneron Pharmaceuticals Business Overview
- 4.6.3 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Product Portfolio
- 4.6.5 Regeneron Pharmaceuticals Recent Developments
- 4.7 Valeant Pharmaceuticals International
- 4.7.1 Valeant Pharmaceuticals International Company Information
- 4.7.2 Valeant Pharmaceuticals International Business Overview
- 4.7.3 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Product Portfolio
- 4.7.5 Valeant Pharmaceuticals International Recent Developments
- 4.8 Bayer AG
- 4.8.1 Bayer AG Company Information
- 4.8.2 Bayer AG Business Overview
- 4.8.3 Bayer AG Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer AG Ophthalmic Steroids Drug Product Portfolio
- 4.8.5 Bayer AG Recent Developments
- 4.9 GlaxoSmithKline
- 4.9.1 GlaxoSmithKline Company Information
- 4.9.2 GlaxoSmithKline Business Overview
- 4.9.3 GlaxoSmithKline Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GlaxoSmithKline Ophthalmic Steroids Drug Product Portfolio
- 4.9.5 GlaxoSmithKline Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Ophthalmic Steroids Drug Product Portfolio
- 4.10.5 Pfizer Recent Developments
5 Global Ophthalmic Steroids Drug Market Scenario by Region
- 5.1 Global Ophthalmic Steroids Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ophthalmic Steroids Drug Sales by Region: 2021-2032
- 5.2.1 Global Ophthalmic Steroids Drug Sales by Region: 2021-2026
- 5.2.2 Global Ophthalmic Steroids Drug Sales by Region: 2027-2032
- 5.3 Global Ophthalmic Steroids Drug Revenue by Region: 2021-2032
- 5.3.1 Global Ophthalmic Steroids Drug Revenue by Region: 2021-2026
- 5.3.2 Global Ophthalmic Steroids Drug Revenue by Region: 2027-2032
- 5.4 North America Ophthalmic Steroids Drug Market Facts & Figures by Country
- 5.4.1 North America Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ophthalmic Steroids Drug Sales by Country (2021-2032)
- 5.4.3 North America Ophthalmic Steroids Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Ophthalmic Steroids Drug Market Facts & Figures by Country
- 5.5.1 Europe Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ophthalmic Steroids Drug Sales by Country (2021-2032)
- 5.5.3 Europe Ophthalmic Steroids Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Ophthalmic Steroids Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ophthalmic Steroids Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ophthalmic Steroids Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ophthalmic Steroids Drug Market Facts & Figures by Country
- 5.7.1 South America Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ophthalmic Steroids Drug Sales by Country (2021-2032)
- 5.7.3 South America Ophthalmic Steroids Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Ophthalmic Steroids Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ophthalmic Steroids Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ophthalmic Steroids Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Ophthalmic Steroids Drug Sales by Type (2021-2032)
- 6.1.1 Global Ophthalmic Steroids Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Ophthalmic Steroids Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Ophthalmic Steroids Drug Revenue by Type (2021-2032)
- 6.2.1 Global Ophthalmic Steroids Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ophthalmic Steroids Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Ophthalmic Steroids Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ophthalmic Steroids Drug Sales by Application (2021-2032)
- 7.1.1 Global Ophthalmic Steroids Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Ophthalmic Steroids Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Ophthalmic Steroids Drug Revenue by Application (2021-2032)
- 7.2.1 Global Ophthalmic Steroids Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ophthalmic Steroids Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Ophthalmic Steroids Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ophthalmic Steroids Drug Value Chain Analysis
- 8.1.1 Ophthalmic Steroids Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ophthalmic Steroids Drug Production Mode & Process
- 8.2 Ophthalmic Steroids Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ophthalmic Steroids Drug Distributors
- 8.2.3 Ophthalmic Steroids Drug Customers
9 Global Ophthalmic Steroids Drug Analyzing Market Dynamics
- 9.1 Ophthalmic Steroids Drug Industry Trends
- 9.2 Ophthalmic Steroids Drug Industry Drivers
- 9.3 Ophthalmic Steroids Drug Industry Opportunities and Challenges
- 9.4 Ophthalmic Steroids Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst